Dermapharm Holding SE
DMPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $48,375 | $32,526 | $49,667 | $34,553 |
| Dep. & Amort. | $24,699 | $20,056 | $19,953 | $24,489 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1,556 | $15,924 | -$40,157 | $26,815 |
| Other Non-Cash | -$22,494 | -$2,611 | -$25,235 | -$14,133 |
| Operating Cash Flow | $52,136 | $65,895 | $4,228 | $71,724 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11,402 | -$10,442 | -$10,074 | -$11,879 |
| Net Acquisitions | $136 | $0 | $0 | $0 |
| Inv. Purchases | -$12,887 | $0 | $0 | $1,010 |
| Inv. Sales/Matur. | $1,368 | $0 | $0 | $15 |
| Other Inv. Act. | $0 | $508 | $776 | $3,284 |
| Investing Cash Flow | -$22,785 | -$9,934 | -$9,298 | -$7,570 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10,671 | $35,000 | $22,741 | -$53,132 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$56,860 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,186 | -$41,642 | -$22,886 | -$8,924 |
| Financing Cash Flow | -$48,375 | -$6,642 | -$145 | -$62,056 |
| Forex Effect | -$621 | -$1,809 | -$894 | $871 |
| Net Chg. in Cash | -$19,644 | $47,511 | -$6,110 | $2,970 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $191,642 | $115,165 | $121,275 | $118,305 |
| End Cash | $171,998 | $162,676 | $115,165 | $121,275 |
| Free Cash Flow | $40,734 | $55,453 | -$5,846 | $59,845 |